Is NWL Netherlands Services B.V. FDA approved?

NWL Netherlands Services B.V. holds 1 FDA-registered establishment in the Netherlands. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are NWL Netherlands Services B.V.'s drugs manufactured?

The FDA register lists Hillegom. Registered operations: analytical testing, finished drug manufacture, relabelling, repackaging.

NWL Netherlands Services B.V.

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: Netherlands

Authorisation

Registered operations

Analytical testing1Finished drug manufacture1Relabelling1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
NWL Netherlands Services B.V.	Amperestraat 12, Hillegom, Zuid-Holland HB 2181, Netherlands (NLD)	Analytical testing, Finished drug manufacture, Relabelling, Repackaging	3003696942494692088

Compare

Comparable companies in Netherlands

Fagron Services B.V.1 site · 75 NDC
Aspen Oss B.V.1 site · 46 NDC
EZUF NL B.V.1 site · 17 NDC
Bioconnection B.V.1 site · 1 NDC
D.O.R.C. Dutch Ophthalmic Research Center (International) B.V.2 sites · 2 NDC
Bioseutica B.V.2 sites · 1 NDC
Eurofins BioPharma Product Testing Leiden B.V.2 sites · 0 NDC
Organon LLC4 sites · 95 NDC

Enquiry

Common questions

Is NWL Netherlands Services B.V. FDA approved?: NWL Netherlands Services B.V. holds 1 FDA-registered establishment in the Netherlands. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are NWL Netherlands Services B.V.'s drugs manufactured?: The FDA register lists Hillegom. Registered operations: analytical testing, finished drug manufacture, relabelling, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.